Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling pdk 1'

Search results for: 'research area pi3k akt signaling pdk 1'

Items 21-30 of 115

Page
per page
  1. R406
    A8546 R406
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and ATP-competitive
      ≥31.45 mg/mL
  2. UNC2881
    B4357 UNC2881
    Target: Mer tyrosine kinase
    Summary: Mer tyrosine kinase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥13.55 mg/mL
  3. CP-673451
    B2173 CP-673451
    Target: PDGFR
    Summary: PDGFRα/β inhibitor,potent and selective
  4. BMS-599626 Hydrochloride
    A3252 BMS-599626 Hydrochloride
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥29.05 mg/mL
  5. Cabozantinib (XL184, BMS-907351)
    A2977 Cabozantinib (XL184, BMS-907351)
    Summary: VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor
      ≥25.08 mg/mL
  6. AG-1024
    A2673 AG-1024
    Summary: Selective IGF-1R inhibitor
  7. Quizartinib (AC220)
    A5793 Quizartinib (AC220)
    Target: FLT3
    Summary: FLT3 inhibitor,potent and selective
      ≥28.03 mg/mL
  8. Imatinib Mesylate (STI571)
    A1805 Imatinib Mesylate (STI571)
    Target: PDGFR|c-Kit|Bcr-Abl
    Summary: Abl/c-kit/PDGFR inhibitor
      ≥29.5 mg/mL
  9. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: HER2 inhibitor,potent and selective
      ≥23.5 mg/mL
  10. R428
    A8329 R428
     10 Citation
    Summary: Selective Axl inhibitor
      ≥25 mg/mL

Items 21-30 of 115

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 5item
  2. Axl 3item
  3. ALK 10item
  4. BMX Kinase 1 item
  5. Broad Spectrum Protein Kinase Inhibitor 3item
  6. c-FMS 2item
  7. c-Kit 2item
  8. c-MET 4item
  9. c-RET 3item
  10. CSF-1R 1 item
  11. DDR1/DDR2 Receptor 1 item
  12. EGFR 14item
  13. FAK 3item
  14. FGFR 8item
  15. FLT3 7item
  16. HER2 5item
  17. IGF1R 5item
  18. Insulin Receptor 2item
  19. IRAK 3item
  20. ITK 1 item
  21. Lck 1 item
  22. LRRK2 4item
  23. PDGFR 9item
  24. Pyk2 1 item
  25. ROR 2item
  26. Spleen Tyrosine Kinase (Syk) 4item
  27. Src 8item
  28. Tie-2 2item
  29. Trk 1 item
  30. VEGFR 27item
Specificity
  1. Selective 47item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 4item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. FLT3 6item
  6. VEGFR 23item
  7. PDGFR 12item
  8. c-Kit 6item
  9. RET 2item
  10. IRAK 3item
  11. Bcr-Abl 6item
  12. FGFR 4item
  13. Insulin-like growth factor receptors(IGFRs) 1 item
  14. MET 1 item
  15. Src 7item
  16. Trk Receptors 2item
  17. EGFR 4item
  18. BMP and Other Activin Receptors 2item
  19. JAK 1 item
  20. Syk 3item
  21. c-MET 3item
  22. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  23. LRRK2 2item
  24. Insulin and Insulin-like Receptors 1 item
  25. ALK 1 item
  26. Tie-2 2item
  27. Ron 1 item
  28. c-Fyn 1 item
  29. Insulin Receptors 1 item
  30. IRG-1R 1 item
  31. ZAP-70 1 item
  32. Fyn kinase 1 item
  33. c-Fms tyrosine kinase 1 item
  34. Mer tyrosine kinase 1 item
  35. ITK 1 item
  36. DCLK2 1 item
Reported Experiments
  1. Animal Experiments 54item
  2. Cell Experiments 37item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 3item
  6. Breast Cancer 10item
  7. Cancer 36item
  8. Cervical Cancer 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 1 item
  11. Colon Carcinoma 3item
  12. Colorectal Cancer 9item
  13. Glioblastoma 4item
  14. Glioma 1 item
  15. Leukemia 2item
  16. Liver Cancer 1 item
  17. Lung Cancer 4item
  18. Lung Carcinoma 2item
  19. Lymphoma 2item
  20. Melanoma 1 item
  21. Multiple Myeloma 2item
  22. Myeloma 1 item
  23. Non-small Cell Lung Cancer 5item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 3item
  26. Prostate Cancer 4item
  27. Pulmonary Arterial Hypertension 1 item
  28. Renal Cancer 2item
  29. Renal Cell Carcinoma 2item
  30. Thyroid Cancer 3item